• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子诊断与癌症预后——简明综述

Molecular Diagnosis and Cancer Prognosis-A Concise Review.

作者信息

Thenrajan Thatchanamoorthy, Alwarappan Subbiah, Wilson Jeyaraj

机构信息

Polymer Electronics Lab., Department of Bioelectronics and Biosensors, Alagappa University, Karaikudi 630003, Tamil Nadu, India.

CSIR-Central Electrochemical Research Institute, Karaikudi 630003, Tamilnadu, India.

出版信息

Diagnostics (Basel). 2023 Feb 17;13(4):766. doi: 10.3390/diagnostics13040766.

DOI:10.3390/diagnostics13040766
PMID:36832253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9955694/
Abstract

Cancer is a complicated disease. Globally, it is one of the major causes for morbidity and mortality. A critical challenge associated with it is the difficulty to accurately diagnose it at an early stage. The malignancy due to multistage and heterogeneity that result from genetic and epigenetic modifications poses critical challenge to diagnose and monitor the progress at an early stage. Current diagnostic techniques normally suggest invasive biopsy procedure that can cause further infections and bleeding. Therefore, noninvasive diagnostic methods with high accuracy, safety and earliest detection are the needs of the hour. Herein, we provide a detailed review on the advanced methodologies and protocols developed for the detection of cancer biomarkers based on proteins, nucleic acids and extracellular vesicles. Furthermore, existing challenges and the improvements essential for the rapid, sensitive and noninvasive detection have also been discussed.

摘要

癌症是一种复杂的疾病。在全球范围内,它是发病和死亡的主要原因之一。与之相关的一个关键挑战是难以在早期准确诊断。由基因和表观遗传修饰导致的多阶段和异质性所引发的恶性肿瘤,对早期诊断和病情进展监测构成了重大挑战。当前的诊断技术通常建议采用侵入性活检程序,这可能会导致进一步的感染和出血。因此,具有高精度、安全性和最早检测能力的非侵入性诊断方法是当务之急。在此,我们对基于蛋白质、核酸和细胞外囊泡检测癌症生物标志物所开发的先进方法和方案进行了详细综述。此外,还讨论了现有挑战以及实现快速、灵敏和非侵入性检测所必需的改进措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/894e7b042f25/diagnostics-13-00766-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/32c7180bea19/diagnostics-13-00766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/da1348c65f7d/diagnostics-13-00766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/94a964e735c5/diagnostics-13-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/6ee6b0f4be6b/diagnostics-13-00766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/42fb8a76c965/diagnostics-13-00766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/086c6ee7ac92/diagnostics-13-00766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/5045a71bcc2b/diagnostics-13-00766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/5589e217bfb2/diagnostics-13-00766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/c8f8a5ab025a/diagnostics-13-00766-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/894e7b042f25/diagnostics-13-00766-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/32c7180bea19/diagnostics-13-00766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/da1348c65f7d/diagnostics-13-00766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/94a964e735c5/diagnostics-13-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/6ee6b0f4be6b/diagnostics-13-00766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/42fb8a76c965/diagnostics-13-00766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/086c6ee7ac92/diagnostics-13-00766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/5045a71bcc2b/diagnostics-13-00766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/5589e217bfb2/diagnostics-13-00766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/c8f8a5ab025a/diagnostics-13-00766-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b8/9955694/894e7b042f25/diagnostics-13-00766-g010.jpg

相似文献

1
Molecular Diagnosis and Cancer Prognosis-A Concise Review.分子诊断与癌症预后——简明综述
Diagnostics (Basel). 2023 Feb 17;13(4):766. doi: 10.3390/diagnostics13040766.
2
Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.卵巢癌管理中的表观遗传生物标志物:当前展望
Front Cell Dev Biol. 2019 Sep 19;7:182. doi: 10.3389/fcell.2019.00182. eCollection 2019.
3
Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.尿细胞外囊泡包裹的 miRNA 特征:膀胱癌诊断和分类的新范式。
Urol Oncol. 2024 Jul;42(7):179-190. doi: 10.1016/j.urolonc.2024.03.006. Epub 2024 Apr 8.
4
Extracellular Vesicles for Childhood Cancer Liquid Biopsy.用于儿童癌症液体活检的细胞外囊泡
Cancers (Basel). 2024 Apr 26;16(9):1681. doi: 10.3390/cancers16091681.
5
Novel biomarkers for early detection of gastric cancer.用于胃癌早期检测的新型生物标志物。
World J Gastroenterol. 2023 May 7;29(17):2515-2533. doi: 10.3748/wjg.v29.i17.2515.
6
Liquid Biopsy in Coronary Heart Disease.液体活检在冠心病中的应用。
Methods Mol Biol. 2023;2695:279-293. doi: 10.1007/978-1-0716-3346-5_19.
7
Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.基于 DNA 甲基化的液体活检作为肺癌检测和预后的生物标志物。
Clin Epigenetics. 2022 Sep 24;14(1):118. doi: 10.1186/s13148-022-01337-0.
8
Current advances in detecting genetic and epigenetic biomarkers of colorectal cancer.结直肠癌基因和表观遗传生物标志物检测的当前进展
Biosens Bioelectron. 2023 Nov 1;239:115611. doi: 10.1016/j.bios.2023.115611. Epub 2023 Aug 19.
9
Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.基于游离细胞 DNA 甲基化的卵巢癌诊断和预后。
Cancer Control. 2024 Jan-Dec;31:10732748241255548. doi: 10.1177/10732748241255548.
10
Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection.血液衍生的细胞外囊泡作为一种有前途的液体活检诊断工具用于早期癌症检测。
Biomolecules. 2024 Jul 14;14(7):847. doi: 10.3390/biom14070847.

引用本文的文献

1
Involvement of lncRNA in cancer diagnosis and prognosis and clinical implications.长链非编码RNA在癌症诊断、预后及临床应用中的作用
Rep Pract Oncol Radiother. 2025 Aug 7;30(3):439-450. doi: 10.5603/rpor.106487. eCollection 2025.
2
Bioinformatic Analysis Reveals Bone Marrow Kinase as a Potential Diagnostic and Prognostic Biomarker for Multiple Cancer Types.生物信息学分析揭示骨髓激酶作为多种癌症类型的潜在诊断和预后生物标志物。
Cureus. 2024 Aug 29;16(8):e68093. doi: 10.7759/cureus.68093. eCollection 2024 Aug.
3
Isotopic Composition of C, N, and S as an Indicator of Endometrial Cancer.

本文引用的文献

1
Metal-Oxide Nanomaterials Synthesis and Applications in Flexible and Wearable Sensors.金属氧化物纳米材料的合成及其在柔性和可穿戴传感器中的应用
ACS Nanosci Au. 2021 Nov 29;2(2):64-92. doi: 10.1021/acsnanoscienceau.1c00029. eCollection 2022 Apr 20.
2
Recent Advances in CRISPR/Cas-Based Biosensors for Protein Detection.基于CRISPR/Cas的蛋白质检测生物传感器的最新进展
Bioengineering (Basel). 2022 Sep 28;9(10):512. doi: 10.3390/bioengineering9100512.
3
Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis.
碳、氮和硫的同位素组成作为子宫内膜癌的一个指标
Cancers (Basel). 2024 Sep 16;16(18):3169. doi: 10.3390/cancers16183169.
4
Progress and Outlook on Electrochemical Sensing of Lung Cancer Biomarkers.电化学检测肺癌生物标志物的研究进展与展望。
Molecules. 2024 Jul 2;29(13):3156. doi: 10.3390/molecules29133156.
5
Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers.早期癌症检测的生物标志物:近期进展全景,聚焦胰腺癌和肝癌
ACS Pharmacol Transl Sci. 2024 Feb 14;7(3):586-613. doi: 10.1021/acsptsci.3c00346. eCollection 2024 Mar 8.
基于CRISPR的分子诊断生物传感器和生物测定的研究进展
Front Bioeng Biotechnol. 2022 Sep 16;10:986233. doi: 10.3389/fbioe.2022.986233. eCollection 2022.
4
The roles of extracellular vesicles in the immune system.细胞外囊泡在免疫系统中的作用。
Nat Rev Immunol. 2023 Apr;23(4):236-250. doi: 10.1038/s41577-022-00763-8. Epub 2022 Aug 4.
5
Nano pom-poms prepared exosomes enable highly specific cancer biomarker detection.纳米蓬蓬球制备的外泌体能够实现高特异性的癌症生物标志物检测。
Commun Biol. 2022 Jul 4;5(1):660. doi: 10.1038/s42003-022-03598-0.
6
Single extracellular vesicle analysis for early cancer detection.单细胞外囊泡分析用于早期癌症检测。
Trends Mol Med. 2022 Aug;28(8):681-692. doi: 10.1016/j.molmed.2022.05.003. Epub 2022 May 24.
7
Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test.使用基于细胞外囊泡蛋白的血液检测进行早期多癌检测。
Commun Med (Lond). 2022 Mar 17;2:29. doi: 10.1038/s43856-022-00088-6. eCollection 2022.
8
Iron (Fe)-doped mesoporous 45S5 bioactive glasses: Implications for cancer therapy.铁(Fe)掺杂的介孔45S5生物活性玻璃:对癌症治疗的启示。
Transl Oncol. 2022 Jun;20:101397. doi: 10.1016/j.tranon.2022.101397. Epub 2022 Mar 30.
9
Tetrahedral DNA Framework-Programmed Electrochemical Biosenors with Gold Nanoparticles for Ultrasensitive Cell-Free DNA Detection.用于超灵敏无细胞DNA检测的含金纳米颗粒的四面体DNA框架编程电化学生物传感器
Nanomaterials (Basel). 2022 Feb 16;12(4):666. doi: 10.3390/nano12040666.
10
Multiplexed Profiling of Extracellular Vesicles for Biomarker Development.用于生物标志物开发的细胞外囊泡多重分析
Nanomicro Lett. 2021 Dec 2;14(1):3. doi: 10.1007/s40820-021-00753-w.